首页> 中文期刊> 《医学信息》 >探讨四种急性时相蛋白对肝硬化继发感染的早期诊断价值

探讨四种急性时相蛋白对肝硬化继发感染的早期诊断价值

         

摘要

目的:探讨肝硬化继发感染时测定各种急性期蛋白(APP)对此病早期诊断的临床价值。方法对61例肝硬化继发感染的患者进行4种急性期蛋白(CRP、AAG、CER和HPT)的动态检测,61例肝硬化继发感染者中34例患者继发感染,在感染控制前后均进行监测,其余27例肝硬化患者没有并发感染,测定一般情况下的4中急性期蛋白。结果61例患者中继发感染的34例患者的急性期蛋白都比感染前高,组内差异有具有实际意义。经临床治疗感染后,急性期蛋白的水平均下降,但持续高于感染之前水平。结论4种肝硬化的急性期蛋白值水平的变化对于观察关英华继发感染和指导进行抗感染治疗,估计临床治疗预后有很大的临床价值。%Objective the determination of al kinds of acute phase proteins to investigate the infection secondary to liver cirrhosis (APP) clinical value in the early diagnosis of this disease. Methods:4 acute phase proteins in 61 patients with hepatic cirrhosis complicated with infection (CRP,AAG,CER and HPT) dynamic detection,61 cases of liver cirrhosis secondary infection in 34 patients with secondary infection,the infection control both before and after the monitor,the remaining 27 cirrhotic patients without concurrent infection,acute period determination case 4 protein. Results of 61 cases of acute phase protein in 34 patients with secondary infection than infection before the high,the dif erences within groups has practical significance. The clinical treatment after infection,acute phase protein level decreased,but before continuing higher infection levels. Conclusion the four cirrhosis and acute phase protein level changes for the observation Guan Yinghua secondary infection and guidance for anti infection treatment, is estimated to have great clinical value in clinical treatment and prognosis.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号